CAR T-Cell therapy for the management of mantle cell lymphoma.
Mol Cancer
; 22(1): 67, 2023 03 31.
Article
in En
| MEDLINE
| ID: mdl-37004047
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Lymphoma, Mantle-Cell
/
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Mol Cancer
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
China